Low Dose Induction for Pediatric Acute Myeloid Leukemia Patients
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
the standard induction treatment for pediatric acute myeloid leukemia has high early morbidity and mortality that jeopardize the outcome especially in developing countries. SIOP recommended lower dose induction synergistic G- CSF to minimize these unwanted toxicities. the study aimed at minimizing the toxicities during induction without jeopardizing the survival.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Dzieci z nowo rozpoznaną białaczką ostrą (AML)
- •Wiek do 18 lat włącznie
✗ Disqualifies
- •Białaczka promieloblastyczna
- •Zespół Downa z białaczką ostrą u dzieci poniżej 4 lat
- •Białaczka wynikająca z zespołu mielodysplastycznego lub wcześniejszego leczenia chemioterapią
- •Dzieci, które zmarły przed rozpoczęciem leczenia
Simplified criteria — AI translation
Trial details
- Maximum age
- 18 Years
- Last updated (source)
- October 9, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (2)
South Egypt Cancer Institute, Assiut Univeristy
Asyut, Egypt
South Egypt Cancer Institute, Assiut Univeristy
Asyut, Egypt
Trial contact
Azza Shibl, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/10/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.